Hulkette is the latest New Champion to get her full introduction in the comics, and the other additions have been showing up across the Marvel Universe. Liberty showed up in the pages of Spider ...

Disney Jr. announces its new series "Marvel's Iron Man and his Awesome Friends," which focuses on a young Tony Stark. It'll debut in summer, 2025. LOS ANGELES -- Disney Jr. has announced it's ...

New York Comic Con is in full swing and Marvel has already teased some of its upcoming projects by giving fans some new and fresh first looks at major characters. The first looks have been ...

A new drug for people who have one of the worst forms of multiple sclerosis aims to make treatment much easier for patients. Ocrevus is a medicine commonly used to treat primary progressive MS ...

Marvel And Sony Reportedly Have A New Strategy For Sharing Spider-man Characters, And We Have To Wonder How It’ll Affect Tom Holland’s Return CinemaBlend October 14, 2024 at 2:00 PM ...

Last year saw the release of the much-anticipated spidey sequel Marvel's Spider-Man 2, but there are plenty of new Marvel projects in the works from myriad top developers that will put some major ...

Decades of mismanagement and financial neglect have turned the New York State Museum ... the projects’ supporters see an opening. By Ana Ley As Ms. Harris rose to center stage, the actor ...

A new initiative by the U.S. Department of the Treasury will help some small businesses in Mississippi, officials said Thursday in a call with reporters. “Small business is the backbone of the ...

Trump Thinks the Border Got Him Elected in 2016. He’s Convinced It Will Do So Again. Voters rank the economy and cost of living as their top issue. Donald Trump believes immigration “beats out ...

Oct. 16, 2024 — From Tasmania to Madagascar to New Guinea, islands make up just over five per cent of Earth's land yet are home to 31 per cent of the world's plant species. A new study shows ...

2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).